Serotonin syndrome: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett m (typo) |
imported>Robert Badgett |
||
| Line 6: | Line 6: | ||
==See also== | ==See also== | ||
* [[Neuroleptic malignant | * [[Neuroleptic malignant syndrome]] | ||
Revision as of 06:39, 2 April 2008
Serotonin syndrome is an "adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor."[1]
References
- ↑ Anonymous (2024), Serotonin syndrome (English). Medical Subject Headings. U.S. National Library of Medicine.